LITE DEPALMA GREENBERG, LLC

Allyn Z. Lite

Michael E. Patunas

Mayra V. Tarantino

Two Gateway Center, 12th Floor

Newark, New Jersey 07102

Telephone: (973) 623-3000

Facsimile: (973) 877-3872

alite@litedepalma.com

mpatunas@litedepalma.com

mtarantino@litedepalma.com

Attorneys for Defendants Hanmi USA, Inc.,

Hanmi Pharmaceutical Co., Ltd.,

Hanmi Fine Chemical Co., Ltd., and Hanmi 

Holdings Co., Ltd.

IN THE UNITED STATES DISTRICT COURT

THE DISTRICT OF NEW JERSEY

ASTRAZENECA AB, AKTIEBOLAGET 

HÄSSLE, ASTRAZENECA LP, KBI INC., 

and KBI-E INC.,

Plaintiffs and 

 Counterclaim Defendants,

v.

HANMI USA, INC., HANMI 

PHARMACEUTICAL CO., LTD., HANMI 

FINE CHEMICAL CO., LTD, and HANMI 

HOLDINGS CO., LTD.,

Defendants and 

Counterclaim Plaintiffs. 

 

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

Civil Action No. 3:11-CV-00760-JAP-TJB

DECLARATION OF RENITA S. RATHINAM IN SUPPORT OF 

DEFENDANTS’ RESPONSIVE MARKMAN SUBMISSION

Case 3:11-cv-00760-JAP-TJB Document 175 Filed 01/06/12 Page 1 of 3 PageID: 6702
1

I, Renita S. Rathinam, state and declare as follows: 

1. I am an attorney at law in the District of Columbia and an associate of Sughrue 

Mion, PLLC, attorneys for Defendants Hanmi USA, Inc., Hanmi Pharmaceutical Co., Ltd., 

Hanmi Fine Chemical Co., Ltd. and Hanmi Holdings Co., Ltd. (collectively “Hanmi”).

2. I submit this declaration in support of Hanmi’s Responsive Markman Submission.

3. True and accurate copies of the exhibits listed in the following table are being 

filed in support of Hanmi’s Responsive Markman Submission. 

Exhibit No. Description

1 Excerpts of 12/6/11 Deposition Transcript of Stephen G. Davies, Ph.D

2 Excerpts of 12/16/11 Deposition Transcript of Jerry L. Atwood, Ph.D

3 GESSNER G. HAWLEY, THE CONDENSED CHEMICAL DICTIONARY 105, 125, 479, 

882 (Van Nostrand Reinhold Co.) (10th ed. 1981).

4 Christoph Y. Yung, A Synopsis on Metals in Medicine and Psychiatry, 21:1 

PHARM. BIOCHEMISTRY & BEHAV. 41-47 (1984).

5 Pragya Sharma et al., Beryllium-induced Toxicity and its Prevention by Treatment 

with Chelating Agents, 20 J. APPLIED TOXICOLOGY 313-18 (2000).

6 Exhibit No. 10 of 12/6/11 Deposition of Stephen G. Davies, Ph.D

7

Anuj K. Dalal et al., Acquired Long QT Syndrome and Monomorphic Ventricular 

Tachycardia After Alternative Treatment With Cesium Chloride for Brain Cancer, 

79:8 MAYO CLINIC PROC. 1065-69 (2004).

8 U.S. Patent No. 5,744,165

9 U.S. Patent No. 4,337,257

10 U.S. Patent No. 5,066,652

11 U.S. Patent No. 6,255,502

12

M. Karthikeyan et al., Formulation and Comparative Studies of Diclofenac With 

Ompeprazole [sic] and Diclofenac With Pantoprazole, 1:1 J. PHARM. &

BIOMEDICAL SCIS. 1-4 (2010).

13 Periodic Table of Elements

14 Correspondence between J. Scherling and R. Rothman re the scope of the “R”

group in claims 3 and 10

15 Hanmi First Amended Non-Infringement and Invalidity Contentions Pursuant to L. 

Case 3:11-cv-00760-JAP-TJB Document 175 Filed 01/06/12 Page 2 of 3 PageID: 6703
2

Exhibit No. Description

Pat. R. 3.6

16 Ex parte Diamond, 123 USPQ 167 (Pat. Off. Bd. App. 1959)

I declare under penalty of perjury that the foregoing is true and correct. 

Executed this 6th day of January 2012.

_____________________________________

Renita S. Rathinam 

Case 3:11-cv-00760-JAP-TJB Document 175 Filed 01/06/12 Page 3 of 3 PageID: 6704